Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|March 9, 2017
The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a modelXuequn Xu, Jin Qiu, Yi SunHeliyon|August 17, 2021
VISTA facilitates phagocytic clearance of HIV infected CEM-SS T cellsXuequn Xu, Sean Petersen, Cynthia Rodriguez, et al.Frontiers in Oncology|May 23, 2019
A Metabolism Toolbox for CAR T TherapyXuequn Xu, J N Rashida Gnanaprakasam, John Sherman, et al.Ebiomedicine|October 17, 2017
A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized MiceGuohua Yi, Xuequn Xu, Sojan Abraham, et al.Plos Pathogens|May 18, 2016
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse ModelShi-Dong Ma, Xuequn Xu, Richard Jones, et al.Human Gene Therapy|January 17, 2018
Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer TherapyChien-Fu Hung, Xuequn Xu, Linhong Li, et al.JCI Insight|July 7, 2017
Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis modelNicholas A Zumwalde, Akshat Sharma, Xuequn Xu, et al.Cell Reports|September 23, 2016
Human iNKT Cells Promote Protective Inflammation by Inducing Oscillating Purinergic Signaling in Monocyte-Derived DCsXuequn Xu, Ginger M Pocock, Akshat Sharma, et al.The Journal of Clinical Investigation|December 9, 2014
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesisShi-Dong Ma, Xuequn Xu, Julie Plowshay, et al.Nature Metabolism|July 23, 2020
Inosine is an alternative carbon source for CD8<sup>+</sup>-T-cell function under glucose restrictionTingting Wang, J N Rashida Gnanaprakasam, Xuyong Chen, et al.Pageof 1